Skip to Main Content

Paper Details

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032.
Clin Cancer Res
94
2021
Author NameAffiliation
Malcolm A SmithNational Cancer Institute
Malcolm A SmithNational Cancer Institute
Susan L CohnUniversity of Chicago
John M MarisChildren's Hospital of Philadelphia and University of Pennsylvania School of Medicine
John M MarisChildren's Hospital of Philadelphia and University of Pennsylvania School of Medicine
Rochelle BagatellChildren's Hospital of Philadelphia and University of Pennsylvania School of Medicine
  • 1 - 6

Datasets

Release 1.2